13F-HR filed by Defilade Capital Management, L.P.
Defilade Capital Management, L.P. filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 33 holding rows worth $737,727,220.
- Accession
- 0002088557-26-000002
- Filer
- CIK 2088557
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 33 entries on the cover page, a total value of $737,727,220 stated on the cover page (in dollars after the unit check, H1), rows summing to $737,727,220 with VALUE read as dollars as filed, 13F file number 028-26338. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Pfizer Inc. | 717081103 | COM | 2,203,504 | $54,867,250 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 227,669 | $52,020,090 | dollars as filed | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 362,816 | $50,021,442 | dollars as filed | |
| ICU MED INC | 44930G107 | COM | 340,745 | $48,614,089 | dollars as filed | |
| PACS GROUP INC | 69380Q107 | COM SHS | 1,145,485 | $43,975,169 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 31,950 | $34,336,026 | dollars as filed | |
| STERIS PLC SHS USD | G8473T100 | Stock | 135,307 | $34,303,031 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 1,234,634 | $30,865,850 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 363,454 | $28,949,111 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 161,992 | $28,508,972 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 269,043 | $27,063,035 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 45,662 | $25,861,130 | dollars as filed | |
| SCHEIN HENRY INC | 806407102 | COM | 320,422 | $24,217,495 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 267,212 | $23,330,280 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 1,414,755 | $21,659,899 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 568,619 | $20,197,347 | dollars as filed | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 128,060 | $19,996,569 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 85,694 | $18,273,389 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 244,881 | $16,252,752 | dollars as filed | |
| BECTON DICKINSON & CO | 075887109 | COM | 81,207 | $15,759,842 | dollars as filed | |
| ATRICURE INC | 04963C209 | COM | 397,636 | $15,730,480 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 241,413 | $14,854,142 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 626,754 | $13,186,904 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 656,713 | $10,842,332 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 91,703 | $10,354,186 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 913,090 | $9,514,398 | dollars as filed | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 401,283 | $9,081,034 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 50,000 | $8,702,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 681,663 | $8,275,389 | dollars as filed | |
| TELEFLEX INCORPORATED | 879369106 | COM | 42,850 | $5,229,414 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 3,290,450 | $4,968,580 | dollars as filed | |
| CONMED CORP COM | 207410101 | Stock | 104,129 | $4,227,637 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 215,418 | $3,687,956 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002088557-26-000002 | this filing | 2026-02-13 | acceptance time not in the bulk data set |